Healthcare - Biotechnology - NASDAQ - US
$ 2.01
-10.7 %
$ 74 M
Market Cap
-1.63
P/E
CASH FLOW STATEMENT
-33.6 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
16.4 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
PDS Biotechnology Corporation
| Net Income | -42.9 M |
| Depreciation & Amortization | 17.4 K |
| Capital Expenditures | -4 |
| Stock-Based Compensation | 7.61 M |
| Change in Working Capital | -199 K |
| Others | -2.12 M |
| Free Cash Flow | -33.6 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (42.9) | (40.9) | (16.9) | (14.8) | (7.0) | (40.9) | (50.9) | (38.8) | (28.1) | (12.2) | (6.9) |
| Depreciation & Amortization | 17.4 K | 86 | 5.36 K | 15.6 K | 98.4 K | 0.2 | 0.2 | 0.1 | 53.1 K | 31.2 K | 4.44 K |
| Deferred Income Tax | (2.0) | 0 | 0 | 0 | (0.4) | 2.8 | 0.1 | 0.3 | 0.2 | 35.3 K | 0 |
| Stock Based Compensation | 7.6 | 5.2 | 4.1 | 0.5 | 3.2 | 7.6 | 6.4 | 5.3 | 2.9 | 1.3 | 0.3 |
| Other Operating Activities | 3.8 | 5.5 | 0.2 | 0.2 | (9.4) | 0.5 | 0.4 | 0.2 | 1.9 | (0.6) | 0.9 |
| Change in Working Capital | (0.2) | 4.5 | 75.8 K | 1.1 | (4.6) | (3.4) | 3.1 | 0.8 | 1.3 | 1.7 | (2.3) |
| Cash From Operations | (33.6) | (25.7) | (12.5) | (13.1) | (18.1) | (33.2) | (40.7) | (32.2) | (21.8) | (9.7) | (8.0) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | 4 | 0 | 0 | 0 | 0 | 0 | (0.2) | (0.7) | (1.3) | (0.9) | (0.1) |
| Other Items | 4 | 0 | 0 | 0 | 29.4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 0 | 0 | 0 | 0 | 29.4 | 0 | (0.2) | (0.7) | (1.3) | (0.9) | (0.1) |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22.1 K |
| Total Debt Repaid | 59.3 K | 25.0 | 0 | 0 | 0 | 15.6 K | 5.0 | 9.5 | 2.5 | 1.6 | 100 K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.3 | (0.6) | 0.3 | 70.5 K | 0 | 1.5 | 0.2 | (0.2) | 51.0 | 14.9 | 15.8 |
| Cash From Financing Activities | 16.4 | 34.3 | 48.9 | 29.8 | 0.8 | (20.3) | 22.6 | 9.1 | 139.5 | 16.5 | 15.9 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | (17.3) | 8.6 | 36.4 | 16.7 | 12.1 | (53.4) | (18.3) | (23.8) | 116.5 | 5.9 | 7.7 |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | (33.6) | (25.7) | (12.5) | (13.1) | (18.1) | (33.2) | (40.9) | (32.9) | (23.1) | (10.6) | (8.2) |